[1] Beasley MB,Franks TJ,Galvin JR,et al.Acute fibrinous and organizing pneumonia:a histological pattern of lung injury and possible variant of diffuse alveolar damage[J]. Arch Pathol Lab Med, 2002,126(9):1064-1070. [2] Travis WD,Costabel U,Hansell DM,et al.An Official American Thoracic Society/European Respiratory Society Statement:Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias[J]. Am J Respir Crit Care Med,2013,188(6):733-748. [3] Gomes R, Padrão E, Dabó H,et al.Acute fibrinous and organizing pneumonia:A report of 13 cases in a tertiary university hospital[J]. Medicine,2016,95(27):e4073. [4] Lu J, Yin Q, Zha Y,et al.Acute fibrinous and organizing pneumonia: two case reports and literature review[J]. BMC Pulm Med, 2019,19(1):141. [5] Santos C, Oliveira RC, Serra P,et al.Pathophysiology of acute fibrinous and organizing pneumonia-Clinical and morphological spectra[J]. Pathophysiology,2019,26(3-4):213-217. [6] Garcia BA, Goede T, Mohammed TL.Acute fibrinous organizing pneumonia: A case report and literature review[J]. Curr Probl Diagn Radiol,2015,44(5):469-471. [7] Akhtar A, Ul Abideen Z.Acute fibrinous and organizing pneumonia mas-querading as a lower respiratory tract infection: A case report and review of the literature[J]. BMC Res Notes, 2015,8:38-43. [8] Polak SB, Van Gool IC, Cohen D,et al.A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression[J]. Mod Pathol, 2020,33(11):2128-2138. [9] Kory P, Kanne JP.SARS-CoV-2 organising pneumonia:‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?[J]. BMJ Open Respir Res, 2020,7(1):e000724. [10] Fasanya A,Gandhi V,DiCarlo C,et al. Acute fibrinous and organizing pneumonia in a patient with Sjogren′s syndrome[J].Resp Med Case Rep, 2016,20:28-30. [11] Yamamoto M, Murata K, Kiriu T,et al.Acute Fibrinous and Organizing Pneumonia with Myelodysplastic Syndrome: Corticosteroid Monotherapy Led to Successful Ventilator Weaning[J]. Intern Med, 2016,55(21):3155-3159. [12] Vasu TS, Cavallazzi R, Hirani A,et al.A 64-year-old male with fever and persistent lung infiltrate[J]. Respir Care, 2009,54(9):1263-1265. [13] Nguyen LP,Ahdoot S,Sriratanaviriyakul N,et al.Acute fibrinous and organizing pneumonia associated with allogenic hematopoietic stem cell transplant successfully treated with corticosteroids: A two-patient case series[J]. Investig Med High Impact Case Rep, 2016,4(2):1-6. [14] Alici IO,Yekeler E,Yazicioglu A,et al.A case of acute fibrinous and organizing pneumonia during early postoperative period after lung transplantation[J]. Transplant Proc, 2015,47(3):836-840. [15] Kuza C,Matheos T,Kathman D,Heard SO.Life after acute fibrinous and organizing pneumonia: A case report of a patient 30 months after diagnosis and review of the literature[J]. Crit Care, 2016,31(1):255-261. [16] Bhatti S, Hakeem A, Torrealba J,et al.Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids[J]. Respir Med, 2009,103(11):1764-1767. [17] Hara Y, Shinkai M, Kanoh S,et al.Clinico-pathological analysis referring hemeoxygenase-1 in acute fibrinous and organizing pneumonia patients[J]. Resp Med Case Rep, 2015,14: 53-56. [18] Simmons GL,Chung HM,McCarty JM,et al. Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanercept[J]. Bone Marrow Transplant, 2016, 52(1):141-143. [19] Kashif M, Arya D, Niazi M,et al.A rare case of necrotizing myopathy and fibrinous and organizing pneumonia with anti-EJ antisynthetase syndrome and SSA antibodies[J]. Am J Case Rep, 2017,18:448-453. [20] Jabbour R, Kumar H, Alvi S,et al.An unusual presentation of acute fibrinous and organizing pneumonia[J]. Am J Case Rep, 2017,18:532-536. |